BLOCK 10: Supraventricular Arrhythmias
You must first login to purchase this item.
Learning Objectives By Lesson
Regular Narrow Complex Supraventricular Tachycardias
  • Describe how to differentiate between narrow complex tachycardias
  • Describe the difference between short and long RP tachycardias
  • Create a differential diagnosis for short and long RP tachycardia
  • Describe the mechanism of action of AV nodal reentrant tachycardia (AVNRT)
  • Describe the electrocardiographic features associated with AV nodal reentrant tachycardia (AVNRT)
  • Describe the eletrocardiographic features associated with accessory pathway mediated-orthodromic reentrant tachycardia (ORT)
Atrial Fibrillation & Atrial Flutter
  • Describe and identify the electrocardiographic features associated with atrial fibrillation (AF)
  • Describe the key mechanistic difference between typical and atypical atrial flutter (AFL)
  • Describe the differences between clockwise (CW) and counter-clockwise (CCW) atrial flutter (AFL)
  • Describe and identify the electrocardiographic features associated with clockwise (CW) and counter-clockwise (CCW) atrial flutter (AFL)
  • Describe and identify the electrocardiographic features to identify atypical atrial flutter (AFL)
Atrial Fibrillation Classification & Pathophysiology
  • Describe how to classifty atrial fibrillation (AF)
  • Describe the difference between valvular and non-valvular atrial fibrillation (AF)
  • Identify electrophysiological and anatomical factors that influence the initiation and maintenance of atrial fibrillation (AF)
  • Describe the process of atrial electrical remodeling occurs in atrial fibrillation (AF)
Stroke Risk & Anticoagulation in Atrial Fibrillation
  • Describe how to determine stroke risk in atrial fibrillation (AF)
  • Identify which patients with atrial fibrillation (AF) should be anticoagulated
  • Describe how a rate versus rhythm control approach for atrial fibrillation (AF) alters anticoagulation management
  • Describe the role of aspirin for stroke prevention in atrial fibrillation (AF)
Anticoagulation Selection in Atrial Fibrillation
  • Identify anticoagulant options to use in atrial fibrillation (AF)
  • Describe the mechanism of action of various direct oral anticoagulants (DOACs)
  • Describe the benefits of using direct oral anticoagulants (DOACs) compared to warfarin in atrial fibrillation (AF)
  • Identify some potential disadvantage of direct oral anticoagulants (DOACs)
  • Identify the proper dosage of various direct oral anticoagulants (DOACs) in atrial fibrillation (AF)
  • Describe when apixaban dose reductions for atrial fibrillation (AF) should be considered
  • Describe the effects of various medications (e.g., verpamil) on different direct oral anticoagulants (DOACs)
  • Identify anticoagulation options for atrial fibrillation (AF) in patients with end-stage renal disease or on dialysis
  • Identify reversal agents for various direct oral anticoagulants (DOACs)
Rate vs. Rhythm Control for Atrial Fibrillation
  • Describe how to determine between a rate versus rhythm control approach for atrial fibrillation (AF)
  • Identify target heart rates in atrial fibrillation (AF) management
  • Identify clinical scenarios of when to consider a rhythm control approach for atrial fibrillation (AF)
  • Describe how to manage atrial fibrillation (AF) in the acute and chronic settings
  • Identify important lifestyle modifications to consider in atrial fibrillation (AF) management
Management of Supraventricular Tachycardia & Pre-excited Atrial Fibrillation
  • Describe an acute termination approach for supraventricular tachycardia (SVT)
  • Describe a chronic suppression approach for supraventricular tachycardia (SVT)
  • Identify the role of catheter ablation in supraventricular tachycardia (SVT)
  • Identify hallmark ECG features of pre-excited atrial fibrillation (AF)
  • Describe the risk stratification for symptomatic and asymptomatic patients with ventricular pre-excitation
  • Describe how to manage pre-excited atrial fibrillation (AF)
Contributors: Anthony Kashou, MD; Mahmoud Ismayl, MD; Khalid Saeed Al-Asad, MD; Adnan Halboni, MD; Adolfo Martinez Salazar, MD; Nandan Anavekar, MBBCh
Progress